CRYOPORT, INC. Goodwill, Acquired During Period
CRYOPORT, INC. (CYRX) reported Goodwill, Acquired During Period of $11.10 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2019-11-12
- CRYOPORT, INC. goodwill, acquired during period for the quarter ending 2019-06-30 was $11.10M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 9 month |
|---|---|---|
| 2019-09-30 | $11.10M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $11.10M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |